BML Capital Management LLC Acquires Shares of 2,061,438 Connect Biopharma Holdings Limited (NASDAQ:CNTB)

BML Capital Management LLC bought a new stake in Connect Biopharma Holdings Limited (NASDAQ:CNTB) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 2,061,438 shares of the company’s stock, valued at approximately $2,432,000. Connect Biopharma comprises about 1.8% of BML Capital Management LLC’s holdings, making the stock its 13th largest position.

Connect Biopharma Stock Up 3.0 %

NASDAQ CNTB opened at $1.39 on Wednesday. The firm’s fifty day moving average price is $1.45 and its 200 day moving average price is $1.28. Connect Biopharma Holdings Limited has a 12 month low of $0.53 and a 12 month high of $2.84.

Analyst Upgrades and Downgrades

Separately, HC Wainwright increased their target price on shares of Connect Biopharma from $7.00 to $8.00 and gave the company a “buy” rating in a research report on Wednesday, April 17th.

Connect Biopharma Company Profile

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on developing therapies to treat T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets.